OPPM
PGNX
Opus Point Partners Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-10,891
| Closed | -$88K | – | 51 |
|
|
2018
Q2 | $88K | Hold |
10,891
| – | – | 0.19% | 48 |
|
|
2018
Q1 | $81K | Sell |
10,891
-10,891
| -50% | -$81K | 0.16% | 49 |
|
|
2017
Q4 | $130K | Hold |
21,782
| – | – | 0.11% | 59 |
|
|
2017
Q3 | $160K | Hold |
21,782
| – | – | 0.14% | 59 |
|
|
2017
Q2 | $148K | Sell |
21,782
-21,783
| -50% | -$148K | 0.14% | 59 |
|
|
2017
Q1 | $411K | Buy |
+43,565
| New | +$411K | 0.31% | 42 |
|